HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuichi Endo Selected Research

evocalcet

1/2022Evocalcet with vitamin D receptor activator treatment for secondary hyperparathyroidism.
11/2021Corrigendum to "Efficacy of evocalcet in previously cinacalcet-treated secondary hyperparathyroidism patients," [Kidney Int. Rep. 2021; https://doi.org/10.1016/j.ekir.2021.08.020].
11/2021Efficacy of Evocalcet in Previously Cinacalcet-Treated Secondary Hyperparathyroidism Patients.
6/2020Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism.
1/2020Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis.
1/2019Assessment of CYP-Mediated Drug Interactions for Evocalcet, a New Calcimimetic Agent, Based on In Vitro Investigations and a Cocktail Study in Humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuichi Endo Research Topics

Disease

20Neoplasms (Cancer)
08/2022 - 01/2003
9Secondary Hyperparathyroidism
01/2022 - 01/2019
7Neoplasm Metastasis (Metastasis)
12/2021 - 01/2003
5Infections
10/2014 - 04/2004
4Adenocarcinoma
05/2021 - 08/2018
4Inflammation (Inflammations)
01/2021 - 01/2010
4Body Weight (Weight, Body)
07/2019 - 06/2007
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 02/2008
3Obesity
01/2022 - 05/2019
3Drug-Related Side Effects and Adverse Reactions
01/2022 - 01/2020
3Weight Loss (Weight Reduction)
01/2022 - 06/2007
3Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 08/2018
3Morbid Obesity
06/2009 - 06/2007
2Hypersplenism (Anemia, Splenic)
06/2021 - 01/2008
2Pancreatic Fistula (Pancreatic Fistulas)
05/2021 - 01/2018
2Hepatocellular Carcinoma (Hepatoma)
02/2021 - 10/2009
2Non-alcoholic Fatty Liver Disease
05/2019 - 01/2018
2Arthritis (Polyarthritis)
01/2017 - 10/2011
2Pneumococcal Infections
12/2012 - 01/2012
2Weight Gain
01/2012 - 06/2007
2Hemolysis
12/2006 - 02/2003
1Cholangitis
10/2022
1Cholecystitis
10/2022
1Hypocalcemia
01/2022
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
12/2021
1Acute Cholecystitis
11/2021
1Gallstones (Gallstone)
11/2021
1Colonic Neoplasms (Colon Cancer)
10/2021
1Breast Neoplasms (Breast Cancer)
10/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
05/2021
1Chromosome Aberrations (Chromosome Abnormalities)
02/2021
1Neoplasms, Cystic, Mucinous, and Serous
09/2020
1Lymphatic Metastasis
07/2020
1Carcinoma (Carcinomatosis)
07/2020
1Chronic Renal Insufficiency
06/2020
1Peritonitis
03/2020

Drug/Important Bio-Agent (IBA)

8LectinsIBA
07/2020 - 01/2010
6evocalcetIBA
01/2022 - 01/2019
6Complement System Proteins (Complement)IBA
01/2017 - 02/2009
5Cinacalcet (Sensipar)FDA Link
01/2022 - 01/2019
4CalciumIBA
01/2022 - 01/2020
4Parathyroid Hormone (Parathormone)IBA
01/2022 - 01/2020
4Glucose (Dextrose)FDA LinkGeneric
09/2020 - 01/2012
4Proteins (Proteins, Gene)FDA Link
07/2020 - 01/2003
3Phosphates (Orthophosphate)IBA
11/2021 - 01/2020
3Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
01/2017 - 01/2003
2AntigensIBA
05/2022 - 01/2003
2Pharmaceutical PreparationsIBA
01/2020 - 01/2019
2CollagenIBA
01/2017 - 10/2011
2Collectins (Collectin)IBA
01/2017 - 01/2012
2Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA
01/2017 - 06/2013
2FicolinsIBA
12/2012 - 01/2012
2AdipokinesIBA
01/2012 - 06/2009
2salicylhydroxamic acid (SHAM)IBA
01/2012 - 06/2007
1AntibodiesIBA
05/2022
1Epithelial Cell Adhesion MoleculeIBA
05/2022
1Calcitriol Receptors (Calcitriol Receptor)IBA
01/2022
1Fibroblast Growth Factor-23IBA
01/2022
1Phosphorus (Red Phosphorus)IBA
01/2022
1Imatinib Mesylate (Gleevec)FDA Link
12/2021
1calcium phosphateIBA
11/2021
1pertuzumabIBA
10/2021
1Panitumumab (Vectibix)FDA Link
10/2021
1Monoclonal AntibodiesIBA
06/2021
1Leucine (L-Leucine)FDA Link
06/2021
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
06/2021
1Neutral Amino AcidsIBA
06/2021
1Green Fluorescent ProteinsIBA
02/2021
1Calcibiotic Root Canal SealerIBA
02/2021
1Cationic Amino Acid Transporter 1IBA
02/2021
1Leucovorin (Folinic Acid)FDA Link
01/2021
1TegafurIBA
01/2021
1UracilIBA
01/2021
1Fluorouracil (Carac)FDA LinkGeneric
01/2021
1Ribosomal Protein S6IBA
09/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
09/2020
1FucosyltransferasesIBA
07/2020
1FucoseIBA
07/2020
1Tumor Biomarkers (Tumor Markers)IBA
07/2020
1Anti-Bacterial Agents (Antibiotics)IBA
03/2020
1Dialysis SolutionsIBA
01/2020

Therapy/Procedure

5Hepatectomy
08/2022 - 10/2009
5Gastrectomy
01/2022 - 03/2013
4Therapeutics
05/2022 - 02/2018
4Bariatric Surgery
01/2022 - 06/2007
4Renal Dialysis (Hemodialysis)
01/2022 - 01/2019
4Splenectomy
06/2021 - 06/2006
4Drug Therapy (Chemotherapy)
01/2020 - 01/2008
3Laparoscopic Cholecystectomy
10/2022 - 01/2021
3Pancreaticoduodenectomy
05/2021 - 01/2008
3Pancreatectomy
05/2021 - 01/2018
2Length of Stay
05/2018 - 10/2009
2Operative Surgical Procedures
01/2008 - 01/2007
1Operative Time
08/2022
1Radioimmunotherapy
05/2022
1Adjuvant Chemotherapy
12/2021
1Stents
05/2021
1Radiotherapy
05/2021
1Aftercare (After-Treatment)
01/2021
1Conservative Treatment
03/2020